Physician profile
Fred T Lee
NPI 1427027713
$14,171,539.61
in general payments reported to CMS, 2019-2025
6 companies · $14M in 2025
The $14M reported for 2025 was more than what 99% of Body Imaging providers received nationally (typical 2025 total: $84.96).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $18K · 2021: $4,416 · 2022: $16K · 2023: $6,993 · 2024: $9,802 · 2025: $14M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $14M · Consulting Fee: $11K · Travel and Lodging: $4,997 · Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $14,065,861.09 |
| Consulting Fee | $11,287.50 |
| Travel and Lodging | $4,997.42 |
| Food and Beverage | $525.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $14,070,945.55 | 2024-2025 | |
| Medical Device Business Services, INC. | $79,109.52 | 2019-2024 | Certus 140 |
| Ethicon Endo-Surgery INC. | $15,003.10 | 2019-2023 | Certus 140 |
| Canon Medical Systems USA, INC. | $6,438.09 | 2022-2024 | Rotating Anode X-Ray Tube Assembly, Ct Scanner, Interventional Angiography System |
| Elucent Medical | $28.78 | 2021 | |
| Ethicon INC. | $14.57 | 2025 | Neuwave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.